173 related articles for article (PubMed ID: 8029798)
1. A new assay based on thrombin generation inhibition to detect both protein C and protein S deficiencies in plasma.
Duchemin J; Pittet JL; Tartary M; Béguin S; Gaussem P; Alhenc-Gelas M; Aiach M
Thromb Haemost; 1994 Mar; 71(3):331-8. PubMed ID: 8029798
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
[TBL] [Abstract][Full Text] [Related]
3. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
De Smedt E; Wagenvoord R; Coen Hemker H
Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
[TBL] [Abstract][Full Text] [Related]
4. Measuring thrombin generation based sensitivity to activated protein C using an automated coagulometer (ACL 9000).
Gardiner C; Machin SJ; Mackie IJ
Int J Lab Hematol; 2008 Aug; 30(4):261-8. PubMed ID: 18665822
[TBL] [Abstract][Full Text] [Related]
5. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation in patients after acute deep-vein thrombosis.
ten Cate-Hoek AJ; Dielis AW; Spronk HM; van Oerle R; Hamulyák K; Prins MH; ten Cate H
Thromb Haemost; 2008 Aug; 100(2):240-5. PubMed ID: 18690343
[TBL] [Abstract][Full Text] [Related]
7. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
[TBL] [Abstract][Full Text] [Related]
8. Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.
Tsakiris DA; Settas L; Makris PE; Marbet GA
J Rheumatol; 1990 Jun; 17(6):785-9. PubMed ID: 2167370
[TBL] [Abstract][Full Text] [Related]
9. The extrinsic coagulation activity assay.
Stief TW; Wieczerzak A; Renz H
Clin Appl Thromb Hemost; 2008 Jul; 14(3):303-18. PubMed ID: 18586682
[TBL] [Abstract][Full Text] [Related]
10. The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation.
Tanaka KA; Szlam F; Levy JH
Br J Haematol; 2006 Jul; 134(1):77-82. PubMed ID: 16803571
[TBL] [Abstract][Full Text] [Related]
11. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
[TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
Toulon P
Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
[TBL] [Abstract][Full Text] [Related]
13. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
14. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of changes in endogenous thrombin potential due to heritable disorders of coagulation.
Ghosh K; Mota L; Shetty S; Kulkarni B
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):577-80. PubMed ID: 18685441
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
Váradi K; Siekmann J; Turecek PL; Schwarz HP; Marder VJ
Thromb Haemost; 1999 Dec; 82(6):1673-9. PubMed ID: 10613654
[TBL] [Abstract][Full Text] [Related]
17. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
[TBL] [Abstract][Full Text] [Related]
18. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.
Lisman T; Bakhtiari K; Pereboom IT; Hendriks HG; Meijers JC; Porte RJ
J Hepatol; 2010 Mar; 52(3):355-61. PubMed ID: 20132999
[TBL] [Abstract][Full Text] [Related]
19. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
[TBL] [Abstract][Full Text] [Related]
20. Regulation of prothrombinase activity by protein S.
van 't Veer C; Butenas S; Golden NJ; Mann KG
Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
